These observations are fully compatible with the known functions of TGFβ ligands in tumor progression [67] and immune suppression [68], as well as the adverse effect of TGFBR2 and phosphorylated SMAD2/3 on survival [66]. This evidence concerns the gene TGFBR2 and neoplasm.